Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With that logic let’s do the following:
If drink alcohol, then you can become dizzy
2 If you become dizzy and are elderly then you may fall
3 If you are elderly and fall then statistically you will be dead in a couple days in the floor or in the hospital.
/*These if then statements == pure logic*/
What a pretty silly logic.
DO BETTER
On top of that, there’s this presentation that will be given by Christopher Missling in of all places in Europe, Germany!!!
Nov 08 2023 @ 1720
Execution of a Clinical Trial Using Precision Medicine in Neurological Diseases
Relevance of biomarkers in clinical studies
What can we learn from oncology
Involving whole blood transcriptomics analysis (RNAseq)
https://informaconnect.com/clinical-trials-europe/speakers/christopher-missling/
I’m sure there were more deaths from ARIA-E using those injection therapies, than Blarcamesine and stumbling in the dark.
Are they though…investors?
Or do they themselves have a “hidden” agenda
Kids kids….
In the long term, Anavex looks to be building something that is worth your attention.
Just a matter of time.
Bring on the next gen of AD therapies
Oh I saw your post. Why use them for one AD therapy and not for the second, especially when it’s from the same CO. targeting the same thing.
Oh…right. They are rarely used that’s why.
Time will tell if healthcare will buy into this approved therapy.
Let’s revisit this in say 3 years?
Wait a second.
So for $26k/yr, bi-weekly infusions, MRI for how long….. is actually a step forward for AD therapy?
The weird question is:
“The FDA did not hold a public advisory meeting for lecanemab before approving it.”
Why does everyone seem to think new data will be presented?
Once again defeats the whole purpose of going to an INVESTOR conference if you release any data BEFORE.
Eisai did just activate the patient assistance hotline for the drug.
Would love to see a form signing requirement, much like waving your rights to sue for that very reason.
As beneficial as 6 cups of coffee minus the side effects!
Perhaps. The potential will be much better reflected in the stock price
If you just sit back and watch for a few more months.
FIXED
I don’t assume. Assuming ends up making one look a certain way.
Time will tell who was giving a best effort opinion and who was telling an invented truth.
Good luck to you the New Year’s Eve
One gives his best interpretation while the other omits to create a narrative.
There’s a difference between the two. It’s night and day.
Still Chet compared to the new generation of potential drugs that are in trials.
Hence the heist to get things approved ASAP
A response I could agree with.
Seems as though safety is a non issue for any of the trials.
So if that is so, what’s the chances that Anavex will be AA AND start a P4
A non U.S. BP will do.
Hell, I’d prefer a EU one for there, Aus for there, and Asian one for everywhere else.
Burn the US BP Companies to the ground!!
Especially those that peddle harmful treatment as a benefit to mankind
Bunch of greedy and corrupt S.O.B.s
Let’s chalk that up with a starting list:
Catalysts to drive value throughout 2023
I think “NEVER BEFORE SEEN” is perfectly fine.
Combining Alzheimer’s and stabilize in the same sentence……
Looks like they are mixing up trial attacks. Wasn’t it Rett they used that attack strategy….
Desperation calls for throwing the entire book at Anavex. Heck, surprised they aren’t using the “printing press” days.
He’d eradicate himself if he wanted to expose frauds.
AF and Missling are on two totally different career paths.
M on possibly the breakthrough of this century, AF moving on to that next “awful CEO”.
Nope. There is only 1 reason why the likes of AF attack small promising bios like AVXL or NWBO.
Why would he even waste his breath on these Companies if there was no ulterior motive
You vote your shares how you chose.
As for me, I’ll continue voting FOR.
GLTA
Not sure what you’re insinuating, but my investment, even at this lowly moment, is still a few 100 % green.
I’m no victim of the CEO.
More like a victim of a corrupt WS.
I’m sure OTHER Alzheimer’s tickers will soon hit triple figures AGAIN, trying to pry shares away from retail investors of Anavex.
One last hurrah one might call it.
But I thought knowledgeable people said it was subtraction that was done wrong…..
Some things are purposely omitted for obvious reasons.
What a ticking time bomb Anavex is!!
Soon the media will not have a choice BUT to report it.
Poor Fudsters can’t seriously recommend an injection therapy FAR MORE inferior to A-273 can they…..
That’s what I’m referring to T.
All the Fud about statistics by those that don’t even know how to use it properly. I’m sure of all people a political science hack DOESNT know how.
Knowingly subtracting when it wasn’t even that type of math that needed to be done.
Working overtime today.
Anavex is perfectly fine.
Letting the data speak for the co.
Soon enough A-273 WILL be approved.
99% chance it’s within the next 15 months
I’d think everyone needs a AD drug like Blarcamesine.
No one wants to blink yet is all.
All the fud about missed endpoints….
All noise
The only way IT will be resolved is when Anavex gets approval for an indication. Until then, manipulation at its finest.
The Market……can be a greedy SOB!!
Where did you hear THAT rumor from George
Buyout NO.
License for a number of indications sure.
Heck, keeping the liquid formulation for themselves would be even better.
That doesn’t concern me at all. There’s a great link explaining how exactly everything was calculated, which then shows the work equals exactly what the presentation came up with.
The Fud doesn’t acknowledge or even correct that their very own way of adding is NOT correct.
Attacking Rett, AD, and any/everything Anavex releases shows how desperate the powers that be are.
I’d be afraid too if I was a BP and had $h1t for trial results.
What else to do besides flood iHub and write articles with false/misleading intent.
Great for me as I never thought we would be in the 7’s. Add more.
Do you not remember BIIB had neither last year….?
Yes!
Your loved one had Alzheimer’s, which drug would you pay for him/her to take?
BIIB 2nd try or AVXL
It’s a no brainer.
Ahhh yea… another bogus lawsuit. The M.O.
Although I think a partner would be good, I don’t agree with the reasons.
I’d like to think it would help keep the vultures away from aggressively taking over the co.
Spending 10-15-20 Billion to acquire the co aggressively is cheap compared to the drug lineup value.
I think it’s finally time to partner for Alzheimer’s and end all manipulation games.
Anavex really risks being aggressively taken over the longer they go it alone.
01DEC
ChrisMis day
I can imagine what a short is thinking right now…..